In 2014, I gained an exciting job in a cancer center in Accra-Ghana. I was a young newly qualified pharmacist, and cancer was an emerging disease trend in Ghana and across Africa. I felt truly privileged to be amongst the few Pharmacists helping to combat this disease state. Being the only female Pharmacist in the practice at the time was also such a privilege.

I, Atalay Mulu Fentie, have been working as a clinical pharmacist and oncology pharmacy service case team coordinator since September, 2013 at Tikur Anbessa Specialized Hospital and lecturer at School of Pharmacy, Addis Ababa University since June, 2017. My role is doing cancer related research projects, teaching pharmacy students, supervising nurses doing chemo-admixture and providing accurate and up-to-date evidence based information to other health care team members during major clinical rounds; which all would impact the clinical decision process and even patient treatment outcomes.

I am clinical pharmacist working at the Peter MacCallum Cancer Centre, Victoria, Australia. Through the past few years I have taken on several diverse roles at the Peter Mac, including running an outpatient radiotherapy clinic and conducting a large randomised controlled trial to assess the effectiveness of pharmacy services for our patients.

This position statement, developed by the ISOPP Biosimilars Taskforce, aims to provide the global oncology pharmacy community with guidance to support decisions around biosimilar use.